Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMST01020017 CE(22:2) cPLA2i 1.0 BCD110605C28 13.2 pmol/sample
LMST01020017 CE(22:2) cPLA2i 1.0 BCD110605C30 1.36 pmol/sample
LMST01020017 CE(22:2) cPLA2i 1.0 BCD110605C29 3.31 pmol/sample
LMST01020017 CE(22:2) cPLA2i 20.0 BCD110605C64 6.69 pmol/sample
LMST01020017 CE(22:2) cPLA2i 20.0 BCD110605C66 1.07 pmol/sample
LMST01020017 CE(22:2) cPLA2i 20.0 BCD110605C65 2.85 pmol/sample
LMST01020017 CE(22:2) PLDi 1.0 BCD110605C16 13.8 pmol/sample
LMST01020017 CE(22:2) PLDi 1.0 BCD110605C18 1.84 pmol/sample
LMST01020017 CE(22:2) PLDi 1.0 BCD110605C17 5.41 pmol/sample
LMST01020017 CE(22:2) PLDi 20.0 BCD110605C54 1.82 pmol/sample
LMST01020017 CE(22:2) PLDi 20.0 BCD110605C53 2.08 pmol/sample
LMST01020017 CE(22:2) PLDi 20.0 BCD110605C52 3.9 pmol/sample
LMST01020017 CE(22:2) KDO+cPLA2i 1.0 BCD110605C32 3.26 pmol/sample
LMST01020017 CE(22:2) KDO+cPLA2i 1.0 BCD110605C31 10.4 pmol/sample
LMST01020017 CE(22:2) KDO+cPLA2i 1.0 BCD110605C33 1.71 pmol/sample
LMST01020017 CE(22:2) KDO+cPLA2i 20.0 BCD110605C68 2.83 pmol/sample
LMST01020017 CE(22:2) KDO+cPLA2i 20.0 BCD110605C69 2.54 pmol/sample
LMST01020017 CE(22:2) KDO+cPLA2i 20.0 BCD110605C67 7.82 pmol/sample
LMST01020017 CE(22:2) KDO+PLDi 1.0 BCD110605C19 7.39 pmol/sample
LMST01020017 CE(22:2) KDO+PLDi 1.0 BCD110605C20 2.88 pmol/sample
LMST01020017 CE(22:2) KDO+PLDi 1.0 BCD110605C21 2.24 pmol/sample
LMST01020017 CE(22:2) KDO+PLDi 20.0 BCD110605C57 0.897 pmol/sample
LMST01020017 CE(22:2) KDO+PLDi 20.0 BCD110605C55 4.11 pmol/sample
LMST01020017 CE(22:2) KDO+PLDi 20.0 BCD110605C56 1.16 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+cPLA2i 1.0 BCD110605C38 2.29 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+cPLA2i 1.0 BCD110605C37 10.4 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+cPLA2i 1.0 BCD110605C39 2.06 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+cPLA2i 20.0 BCD110605C74 4.46 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+cPLA2i 20.0 BCD110605C73 8.55 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+cPLA2i 20.0 BCD110605C75 1.41 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+PLDi 1.0 BCD110605C26 3.51 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+PLDi 1.0 BCD110605C27 1.94 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+PLDi 1.0 BCD110605C25 6.29 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+PLDi 20.0 BCD110605C62 1.56 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+PLDi 20.0 BCD110605C63 1.76 pmol/sample
LMST01020017 CE(22:2) KDO+ATP+PLDi 20.0 BCD110605C61 3.91 pmol/sample
LMST01020017 CE(22:2) KDO + ATP 1.0 BCD110605C15 1.66 pmol/sample
LMST01020017 CE(22:2) KDO + ATP 1.0 BCD110605C13 12.2 pmol/sample
LMST01020017 CE(22:2) KDO + ATP 1.0 BCD110605C14 4.14 pmol/sample
LMST01020017 CE(22:2) KDO + ATP 20.0 BCD110605C51 1.97 pmol/sample
LMST01020017 CE(22:2) KDO + ATP 20.0 BCD110605C49 5.88 pmol/sample
LMST01020017 CE(22:2) KDO + ATP 20.0 BCD110605C50 2.37 pmol/sample
LMST01020017 CE(22:2) KDO 1.0 BCD110605C09 2.35 pmol/sample
LMST01020017 CE(22:2) KDO 1.0 BCD110605C08 1.83 pmol/sample
LMST01020017 CE(22:2) KDO 1.0 BCD110605C07 9.85 pmol/sample
LMST01020017 CE(22:2) KDO 20.0 BCD110605C43 5.73 pmol/sample
LMST01020017 CE(22:2) KDO 20.0 BCD110605C44 2.22 pmol/sample
LMST01020017 CE(22:2) KDO 20.0 BCD110605C45 1.53 pmol/sample
LMST01020017 CE(22:2) C 0.0 BCD110605C03 3.03 pmol/sample
LMST01020017 CE(22:2) C 0.0 BCD110605C02 6.36 pmol/sample